Ahead of next week’s meeting of the U.S.-China Joint Commission on Commerce and Trade, 37 members of the U.S. Senate asked Obama administration negotiators to “urge China to move forward in deregulating [biotech] products awaiting final approval.” Lightweight “Urge” Ahead of next week’s meeting of the U.S.-China Joint Commission on Commerce and Trade, 37 members of the U.S. Senate asked Obama administration negotiators to “urge China to move forward in deregulating [biotech] products awaiting final approval.” The request further states that “it is imperative that we hold our trading partners to the commitments they make.” The tepid approach of urging China is unlikely to cause movement in Beijing where most of the handful of trait approva...